Drug Type Small molecule drug |
Synonyms |
Target |
Mechanism PIP4K2A inhibitors(phosphatidylinositol-5-phosphate 4-kinase type 2 alpha inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC14H13N3O2S2 |
InChIKeyQVQHWPLHUNEREE-UHFFFAOYSA-N |
CAS Registry2924824-56-4 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Immune System Diseases | Preclinical | GB | 12 Jan 2023 | |
Neoplasms | Preclinical | GB | 12 Jan 2023 | |
Nervous System Diseases | Preclinical | GB | 12 Jan 2023 |